Suicide risk and learned suicide ability in people with mood disorders
Official title: Investigation on Suicide Risk Factors of Patients With Mood Disorders in China
Run by Tianjin Anding Hospital · NCT07523490 · Data updated 2026-11-12
This project will try to identify which biological, psychological, social, and clinical factors relate to suicide risk and the learned ability for suicide in people aged 16–60 with mood disorders by collecting blood, urine, and questionnaire data.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 16 Years to 60 Years |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Tianjin Anding Hospital Academic / other |
| Locations | 1 site (Tianjin, Tianjin Municipality) |
| Status | Recruiting |
| Started | December 31, 2025 |
| Main results expected | September 30, 2027 |
| Study ends | September 30, 2027 |
| Registry record updated | April 22, 2026 |
| Trial ID | NCT07523490 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are people aged 16–60 who are receiving psychiatric care, meet ICD‑11 mood disorder criteria, are willing to cooperate, and can provide informed consent (guardian consent required for minors).
✕Probably not a fit
Patients with serious organic illnesses that prevent participation, those unable to understand or complete questionnaires, or people without a mood disorder are unlikely to benefit from this project.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study enrolls people aged 16–60 who meet ICD‑11 criteria for mood disorders at Tianjin Anding Hospital. Participants complete standardized scales (Beck Scale for Suicide Ideation, Columbia Suicide Severity Rating Scale, HAMD, HAMA, PHQ‑9, GAD‑7 and functional measures) and provide blood and urine samples for molecular biomarker analysis. Investigators will analyze biological, psychological, social, and clinical data to identify factors tied to suicide risk and the formation of learned suicide ability and will develop a prediction model. No treatments are assigned; the aim is to produce a ranked list of risk factors and a validated predictive tool for learned suicide ability.
Why it matters
Potential benefit: If successful, this work could help clinicians identify patients at higher risk of suicide earlier and tailor prevention efforts more effectively.
How similar studies have gone: Previous multi-dimensional studies have had some success identifying suicide risk markers and building predictive models, but prediction of 'learned suicide ability' is relatively novel and requires more validation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age: 16 to 60 years old; 2. seeing a doctor in a psychiatric clinic or a general hospital; 3. Willing to cooperate in this research project; 4. Sign the informed consent form (minors also need to obtain the informed consent signature of the guardian); 5. Meet the diagnostic criteria of ICD-11 mood disorder. Exclusion Criteria: 1. unable to understand the contents of the questionnaire; 2. Serious organic diseases such as cardiovascular disease, brain disease, liver disease and kidney disease, and weak body, which affect the respondents of the questionnaire; 3. Other circumstances that make it impossible or unwilling to cooperate with the completion of the questionnaire.
Where it's running
-
Tianjin Anding Hospital
Tianjin, Tianjin Municipality, China Recruiting
Study contacts
- Study coordinator: Xue Tian
- Email: 576491743@qq.com
- Phone: +86-13602182093
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Testing a new drug for treatment-resistant depression
This study is testing a new drug called HNK to see if it can help people with treatment-resistant depression feel better when other medications haven't worked.
-
Friends and family training for those at risk of suicide
A six-week program tests whether training for caregivers can help them support a loved one at risk of suicide while also taking care of their own mental health.
-
Videoconference Brief Cognitive Behavioral Therapy for mood disorders at high suicide risk
This study tests a short online CBT program to help people with mood disorders who are at high risk of suicide, and compares inflammatory biomarkers between groups.
-
Digital Mental Health support for Asian Americans
We’re testing online digital tools to help Asian American adults cope with sociocultural stressors, by training clinicians and seeing if outcomes improve for clients.
-
Inhaled DMT for major depressive disorder
This trial tests whether inhaled DMT can quickly ease depressive symptoms and reduce suicide risk in adults with major depressive disorder.
-
Combining the Youth-Nominated Support Team with CBT for Black adolescents at acute suicide risk
This project will test whether adding a computer-assisted Youth-Nominated Support Team to Cognitive Behavioral Therapy for Suicide Prevention helps Black adolescents (ages 12-17) who come to an urban emergency setting with suicidal thoughts or self-injury.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.